Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HORIZONS-AMI
NCT00433966Phase 3Completed
- Sponsor
- Cardiovascular Research Foundation
- Start
- Mar 2005
- Primary completion
- Jun 2008
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bivalirudin in ST elevation myocardial infarction (STEMI), sponsored by Cardiovascular Research Foundation. Started Mar 2005; status: completed.
02
Drugs
bivalirudin
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT00433966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00433966.